Actualités Entrada Therapeutics Inc - TRDA | Actions NASDAQ | ADVFN

Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Entrada Therapeutics Inc (TRDA)
Entrada Therapeutics Inc (TRDA) Actualités

Entrada Therapeutics Inc (TRDA)

18,05

0,12

(0,67%)

Fermé 22 Novembre 10:00PM

Retardé de 15 minutes

18,10

0,05

(0,28%)

Après les heures de négociation: 1:59AM

Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Entrada Therapeutics Announces Recipients of Second Annual Diversity, Representation, Equity and Advocacy MatterS (DREAMS) Grant Program

- Second annual DREAMS Grant Program awards $25,000 each to three U.S.-based non-profit organizations working...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Entrada Therapeutics Reports Second Quarter 2024 Financial Results

– Generated positive data from the Phase 1 clinical trial of ENTR-601-44 for DMD, including dose-dependent...

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

1
2
Suivant

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Entrada Therapeutics

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales